What is Coronavirus?

Duke experts offer a quick explainer and what we know about the new coronavirus in China

Five Selected for Duke National Clinician Scholars Program

Three physicians and two post-doctoral nurses will comprise the 2020-2022 cohort for Duke’s National Clinician Scholars Program (NCSP). The cohort represents the second group of interdisciplinary medical researchers selected for the newly established Duke NCSP site.

Doctors at Duke University Hospital Perform First DCD Heart Transplant

A heart transplant team at Duke University Hospital became the first in the U.S. to transplant an adult heart into a recipient through a process known as Donation after Circulatory Death, or DCD.

Duke is one of five centers in the United States that has been approved to perform DCD heart transplants as part of a recently launched clinical trial of a device to circulate warm, oxygenated blood through organs.

School of Medicine Faculty Recognized on ‘Highly Cited’ List

Fifty-four members of Duke’s faculty are included in the 2019 Highly Cited Researchers list compiled by ISI-Web of Science and Clarivate Analytics. More than half of them (37) are from the School of Medicine. 

A high citation rate is an indication that a researcher’s work is influential in their field. Globally, Duke is in a four-way tie for eighth place with MIT, Memorial Sloan Kettering Cancer Center, and the University of California San Diego. In 2018, Duke was tied for 12th worldwide.

Bridges to Excellence: Improving Diverse Students’ Transitions from College to Medical School

Duke University School of Medicine, the East Carolina University Brody School of Medicine, and the University of South Carolina Greenville School of Medicine are to open a new avenue for talented college students from underrepresented populations to enroll and succeed at leading medical schools in the Carolinas.

Bridges to Excellence (BTE) creates a novel partnership among these schools to recruit and support talented underrepresented students who aspire to provide health care in underserved communities. 

School of Medicine Partners with CSL Behring to Accelerate Faculty Research into new Technologies

In line with the Duke University School of Medicine research strategic plan, which identifies industry partnerships as a critical enabler to support faculty research, the School has formed a promising new partnership with global biotechnology company CSL Behring with the goal of accelerating research and identifying and commercializing new technologies.

The partnership came about as a result of work led by Adrian Hernandez, MD, vice dean of clinical research, who has been actively networking with industry leaders for the past year.

Translating Duke Health Initiative Celebrates Two Years of Success

So far, 24 grants have been awarded totaling more than 2.8 million in seed funding. Eight School of Medicine departments have participated to recruit 17 strategic hires, called TDH Scholars, with additional recruitments ongoing. Twelve million dollars has been earmarked to support research infrastructure to accelerate discovery, including such things as a biobanking resource, and 24 educational symposia were hosted to bring together basic scientists, clinicians, and population health thought leaders.